ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,925Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 1677

$940K Total Retail Price of All Prescriptions

Rank: 82 out of 1677

695 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 695 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,978 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 853 721 1 1
AMLODIPINE BESYLATE 821 666 2 2
FUROSEMIDE 551 495 3 8
LEVOTHYROXINE SODIUM 529 444 4 5
ATORVASTATIN CALCIUM 429 347 5 13
CARVEDILOL 345 271 6 20
BENAZEPRIL-HYDROCHLOROTHIAZIDE 343 266 10 7 139
METFORMIN HCL 329 254 8 7
HYDROCODONE-ACETAMINOPHEN 319 231 S3 9 4
LOSARTAN POTASSIUM 318 284 10 25
NEXIUM 286 124 11 19
METOPROLOL SUCCINATE 282 221 12 23
BENAZEPRIL HCL 279 235 13 53
OMEPRAZOLE 259 227 14 6
CLOPIDOGREL 256 222 15 32
ZOLPIDEM TARTRATE 249 148 16 15
LISINOPRIL 239 162 17 3
WARFARIN SODIUM 232 218 18 24
GABAPENTIN 231 181 19 11
CRESTOR 224 112 20 28
METOPROLOL TARTRATE 223 178 21 12
PRAVASTATIN SODIUM 206 180 22 10
RANITIDINE HCL 201 147 23 18
PANTOPRAZOLE SODIUM 186 152 24 46
PLAVIX 181 154 25 47
POTASSIUM CHLORIDE 161 104 26 14
DIOVAN 156 120 27 45
CITALOPRAM HBR 150 123 28 22
TAMSULOSIN HCL 144 127 29 34
ATENOLOL 142 121 30 21
HYDRALAZINE HCL 136 124 31 69
HYDROCHLOROTHIAZIDE 129 111 32 9
AZITHROMYCIN 127 87 33 38
BENICAR 124 115 34 178
ISOSORBIDE MONONITRATE ER 120 82 35 73
ALENDRONATE SODIUM 118 107 36 43
GLIMEPIRIDE 118 97 36 33
ACETAMINOPHEN-CODEINE 117 72 S3 38 136
LOSARTAN-HYDROCHLOROTHIAZIDE 117 72 38 42
INSULIN SYRINGE 112 83 40 72
MELOXICAM 111 88 41 27
SPIRONOLACTONE 110 103 42 88
CLONIDINE HCL 107 81 43 36
LANTUS 105 67 44 44
GLIPIZIDE XL 104 76 45 123
DONEPEZIL HCL 103 103 46 30
AMOXICILLIN 101 75 47 94
TRAMADOL HCL 99 77 48 16
PREMARIN 99 95 R 48 109
PREDNISONE 92 83 50 40
FLUTICASONE PROPIONATE 88 68 51 29
NAMENDA 87 87 52 39
SPIRIVA 86 73 53 74
ALLOPURINOL 83 70 54 31
CYMBALTA 83 34 54 58
GLIPIZIDE ER 83 70 54 78
ADVAIR DISKUS 83 60 54 54
DIGOXIN 82 70 58 71
METFORMIN HCL ER 80 80 59 51
LIPITOR 80 63 59 101
BYSTOLIC 80 66 59 125
CILOSTAZOL 79 75 62 235
PROAIR HFA 78 40 63 50
SERTRALINE HCL 76 70 64 26
ABILIFY 70 23 65 227
DIOVAN HCT 67 64 66 66
ESCITALOPRAM OXALATE 66 50 67 80
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 53 67 17
IRBESARTAN 63 61 69 366
GLYBURIDE-METFORMIN HCL 62 62 R 70 121
BUMETANIDE 61 61 71 200
ONGLYZA 61 52 71 208
POLYETHYLENE GLYCOL 3350 60 39 73 76
LEVOFLOXACIN 59 42 74 84
PROMETHAZINE HCL 58 43 R 75 64
NIFEDIPINE ER 58 49 75 98
VENLAFAXINE HCL ER 57 34 77 92
METHYLPREDNISOLONE 56 43 78 145
NITROSTAT 56 51 78 246
LYRICA 55 38 80 81
AMITRIPTYLINE HCL 54 45 R 81 63
LORAZEPAM 53 46 82 239
SYMBICORT 52 45 83 150
ROPINIROLE HCL 52 41 83 79
NITROFURANTOIN MONO-MACRO 51 39 85 177
GLIPIZIDE 50 40 86 56
MECLIZINE HCL 50 48 86 110
DEXILANT 50 31 86 179
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.